您的购物车当前为空
STAT3-IN-35 作为一种有效的STAT3抑制剂,主要通过结合SH2结构域发挥作用。该化合物能够阻断STAT3的磷酸化过程,并在三阴性乳腺癌(TNBC)细胞系中显示出抗增殖属性。在TNBC异种移植模型中,STAT3-IN-35 还展示了明显的抗肿瘤活性和毒性。

STAT3-IN-35 作为一种有效的STAT3抑制剂,主要通过结合SH2结构域发挥作用。该化合物能够阻断STAT3的磷酸化过程,并在三阴性乳腺癌(TNBC)细胞系中显示出抗增殖属性。在TNBC异种移植模型中,STAT3-IN-35 还展示了明显的抗肿瘤活性和毒性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 15,000 | 10-14周 | |
| 50 mg | ¥ 19,800 | 10-14周 | |
| 100 mg | ¥ 25,500 | 10-14周 |
STAT3-IN-35 相关产品
| 产品描述 | STAT3-IN-35 is a STAT3 inhibitor that binds to the SH2 domain. This compound inhibits the phosphorylation of STAT3 and exhibits antiproliferative activity in triple-negative breast cancer (TNBC) cell lines. Additionally, STAT3-IN-35 has demonstrated toxicity and potent antitumor activity in TNBC xenograft models. |
| 分子量 | 353.41 |
| 分子式 | C21H23NO4 |
| CAS No. | 2849535-96-0 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容